• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性痛风性关节炎的治疗:一位医生的治疗方法以及该治疗方法与该领域进展的对比情况。

Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.

作者信息

Wortmann Robert L

机构信息

Department of Internal Medicine, The University of Oklahoma College of Medicine, 4502 East 41st Street, Tulsa, OK 74137, USA.

出版信息

Curr Rheumatol Rep. 2004 Jun;6(3):235-9. doi: 10.1007/s11926-004-0074-4.

DOI:10.1007/s11926-004-0074-4
PMID:15134604
Abstract

An attack of acute gouty arthritis is one the most painful episodes that can be experienced by humans. Fortunately, there are three classes of agents that can effectively terminate the acute attack. These include colchicine, nonsteroidal anti-inflammatory drugs, and glucocorticoids. If therapy with any one of these is initiated promptly after the onset of symptoms, relief should occur quickly. Recent observations have increased the knowledge of crystal-induced acute inflammatory responses. These observations allow a better understanding of the mechanisms of action of these agents and provide the rationale for using them in combination in severe or refractory cases.

摘要

急性痛风性关节炎发作是人类所能经历的最痛苦的病症之一。幸运的是,有三类药物可以有效终止急性发作。这些药物包括秋水仙碱、非甾体抗炎药和糖皮质激素。如果在症状出现后迅速开始使用其中任何一种进行治疗,疼痛应会很快缓解。最近的观察增加了对晶体诱导的急性炎症反应的了解。这些观察有助于更好地理解这些药物的作用机制,并为在严重或难治性病例中联合使用它们提供了理论依据。

相似文献

1
Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.急性痛风性关节炎的治疗:一位医生的治疗方法以及该治疗方法与该领域进展的对比情况。
Curr Rheumatol Rep. 2004 Jun;6(3):235-9. doi: 10.1007/s11926-004-0074-4.
2
Management of acute and chronic gouty arthritis: present state-of-the-art.急性和慢性痛风性关节炎的管理:当前的技术水平
Drugs. 2004;64(21):2399-416. doi: 10.2165/00003495-200464210-00003.
3
Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.炎症的机制及急性痛风性关节炎炎症的临床处理。
J Clin Rheumatol. 2013 Jan;19(1):19-29. doi: 10.1097/RHU.0b013e31827d8790.
4
Gouty arthritis: understanding the disease state and management options in primary care.痛风性关节炎:初级保健中对疾病状态和治疗选择的理解。
Adv Ther. 2011 Sep;28(9):748-60. doi: 10.1007/s12325-011-0058-5. Epub 2011 Aug 31.
5
Should patients with interval gout be treated with urate lowering drugs?痛风间歇期患者是否应使用降尿酸药物进行治疗?
J Rheumatol. 1995 Sep;22(9):1621-3.
6
[Therapy of hyperuricemia and gout].[高尿酸血症与痛风的治疗]
Wien Med Wochenschr. 1997;147(16):382-7.
7
Management of gouty arthritis in patients with chronic kidney disease.慢性肾脏病患者痛风性关节炎的管理
Am J Ther. 2014 Nov-Dec;21(6):523-34. doi: 10.1097/MJT.0b013e318250f83d.
8
Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence.卡那单抗治疗难治性痛风性关节炎患者:临床证据综述
Joint Bone Spine. 2015 Oct;82 Suppl 1:eS9-16. doi: 10.1016/S1297-319X(15)30003-8.
9
Current concepts in the treatment of gouty arthritis.痛风性关节炎治疗的当前观念。
Orthop Surg. 2013 Feb;5(1):6-12. doi: 10.1111/os.12024.
10
[Gout and hyperuricaemia--should both be treated?].[痛风与高尿酸血症——二者都需要治疗吗?]
Tidsskr Nor Laegeforen. 2003 Oct 23;123(20):2878-80.

引用本文的文献

1
Management of gout in older adults: barriers to optimal control.老年人痛风的管理:实现最佳控制的障碍
Drugs Aging. 2007;24(1):21-36. doi: 10.2165/00002512-200724010-00002.

本文引用的文献

1
Clinical practice. Gout.临床实践。痛风。
N Engl J Med. 2003 Oct 23;349(17):1647-55. doi: 10.1056/NEJMcp030733.
2
Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.S100A8和S100A9在急性痛风性关节炎气袋模型中对尿酸单钠晶体反应的中性粒细胞募集中的作用。
Arthritis Rheum. 2003 Aug;48(8):2310-20. doi: 10.1002/art.11079.
3
Concomitant septic and gouty arthritis--an analysis of 30 cases.脓毒症合并痛风性关节炎——30例病例分析
Rheumatology (Oxford). 2003 Sep;42(9):1062-6. doi: 10.1093/rheumatology/keg297. Epub 2003 Apr 16.
4
S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity.S100A9/S100A8:S100蛋白家族的髓系代表作为先天免疫中的重要参与者
Microsc Res Tech. 2003 Apr 15;60(6):569-80. doi: 10.1002/jemt.10299.
5
Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion.S100的促炎活性:蛋白质S100A8、S100A9和S100A8/A9可诱导中性粒细胞趋化和黏附。
J Immunol. 2003 Mar 15;170(6):3233-42. doi: 10.4049/jimmunol.170.6.3233.
6
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro.S100A9(MRP14)缺失导致白细胞介素-8诱导的CD11b表面表达减少、微丝系统极化以及体外对趋化因子的反应性降低。
Mol Cell Biol. 2003 Feb;23(3):1034-43. doi: 10.1128/MCB.23.3.1034-1043.2003.
7
Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis.黑皮质素3型受体的激活作为促肾上腺皮质激素在痛风性关节炎中发挥疗效的分子机制。
Arthritis Rheum. 2002 Oct;46(10):2765-75. doi: 10.1002/art.10526.
8
The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis.急性痛风性关节炎期间血清尿酸浓度降低机制中的炎症过程。
J Rheumatol. 2002 Sep;29(9):1950-3.
9
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.依托考昔与吲哚美辛治疗急性痛风性关节炎的随机双盲试验
BMJ. 2002 Jun 22;324(7352):1488-92. doi: 10.1136/bmj.324.7352.1488.
10
Update on colchicine and its mechanism of action.秋水仙碱及其作用机制的最新进展。
Curr Rheumatol Rep. 2002 Jun;4(3):252-6. doi: 10.1007/s11926-002-0073-2.